Search Results - "Shahi, Parham Khosravi"
-
1
State of art of advanced triple negative breast cancer
Published in The breast journal (01-09-2019)“…Advanced triple negative breast cancer (TNBC) is an aggressive disease (high probability of visceral metastasis) with poor outcome. Triple negative breast…”
Get more information
Journal Article -
2
Metastatic triple negative breast cancer: Optimizing treatment options, new and emerging targeted therapies
Published in Asia-Pacific journal of clinical oncology (01-02-2018)“…Triple negative breast cancer (TNBC) is a heterogeneous disease, not only on the molecular level, but also on the pathologic and clinical levels. It also has a…”
Get full text
Journal Article -
3
Phase II study of neoadjuvant treatment with doxorubicin, docetaxel, and capecitabine (ATX) in locally advanced or inflammatory breast cancer
Published in Breast cancer (Tokyo, Japan) (01-07-2010)“…Background Pathologic complete response (pCR) after preoperative systemic chemotherapy (PSCh) is associated with better outcome in locally advanced breast…”
Get full text
Journal Article -
4
Update on the management of older patients with pancreatic adenocarcinoma: a perspective from medical oncology
Published in Clinical & translational oncology (01-07-2024)“…In the context of pancreatic cancer, surgical intervention is typically recommended for localized tumours, whereas chemotherapy is the preferred approach in…”
Get full text
Journal Article -
5
Review of risk of COVID-19 in cancer patients and their cohabitants
Published in International journal of infectious diseases (01-04-2021)“…•Cancer patients had higher seroprevalence of SARS-CoV-2 antibodies than the general population (31.4% vs 10%).•The probability of seropositivity for a cancer…”
Get full text
Journal Article -
6
Tumoral Angiogenesis: Review of the Literature
Published in Cancer investigation (01-01-2008)“…Tumoral angiogenesis is necessary for the growth of neoplasms and the production of metastasis. The vascular endothelial growth factor (VEGF) is a homodimeric…”
Get full text
Journal Article -
7
Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia: Review of the Literature and a Single-center Experience
Published in Curēus (Palo Alto, CA) (13-09-2019)“…Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH) is a rare disorder that is commonly underdiagnosed. In 2015, it was recognized by the…”
Get full text
Journal Article -
8
Low total pathologic complete response rate to preoperative chemotherapy in patients with invasive lobular carcinoma of the breast
Published in Contemporary oncology (Poznań, Poland) (01-01-2019)“…Introduction Total pathologic complete response (tpCR; ypT0/is ypN0) after preoperative chemotherapy (PCT) is associated with better outcome in locally…”
Get full text
Journal Article -
9
Antiangiogenic drugs in the treatment of advanced epithelial ovarian cancer
Published in Anti-cancer agents in medicinal chemistry (01-10-2012)“…Epithelial ovarian cancer (EOC) accounts for approximately 80-90% of all ovarian cancers, and 75% of the patients are diagnosed with advanced disease (stage…”
Get more information
Journal Article -
10
Metastatic Thymic Carcinoma with Long Survival After Treatment with Sunitinib
Published in Curēus (Palo Alto, CA) (14-07-2018)“…Thymic carcinomas are the most aggressive histological subtype of thymic tumors with limited data to guide correct management. No standard treatments are…”
Get full text
Journal Article -
11
Management of non metastatic phyllodes tumors of the breast: Review of the literature
Published in Surgical oncology (01-12-2011)“…Abstract Phyllodes tumors of the breast are rare tumors, accounting for less than 0.5% of all breast tumors. These tumors are comprised of both stromal and…”
Get full text
Journal Article -
12
High-Dose 8% Capsaicin Patch in Treatment of Chemotherapy-Induced Peripheral Neuropathy. A Systematic Review
Published in Journal of pain and symptom management (01-11-2020)“…This is a review of the evidence from studies of the efficacy and tolerability of topically applied and high-concentration (8%) capsaicin in…”
Get full text
Journal Article -
13
Axillary dissection 10 years after Z0011
Published in Journal of clinical oncology (01-06-2022)“…e12582 Background: Axillary involvement is one of the strongest prognostic factors in breast cancer. Axillary lymphadenectomy (AL) has been considered one of…”
Get full text
Journal Article -
14
Seroprevalence of SARS-CoV-2–specific antibodies in cancer outpatients in Madrid (Spain): A single center, prospective, cohort study and a review of available data
Published in Cancer treatment reviews (01-11-2020)“…•We presents the results of the prevalence of IgG and IgM antibodies against SARS-CoV-2 in cancer patients from the University Hospital of Torrejón (Torrejón…”
Get full text
Journal Article -
15
Biomarkers of Immune Checkpoint Inhibitors in Non–Small Cell Lung Cancer: Beyond PD-L1
Published in Clinical lung cancer (01-09-2021)“…Immunotherapy has markedly improved the survival rate of patients with non–small cell lung cancer (NSCLC) and has introduced a new era in lung cancer…”
Get full text
Journal Article -
16
Diffuse large B-cell lymphoma
Published in Medicina clínica (03-06-2006)Get more information
Journal Article -
17
Update on thymic epithelial tumors: a narrative review
Published in Mediastinum (Hong Kong, China) (2024)“…Thymoma, thymic carcinoma and thymic neuroendocrine tumors originate from the epithelial cells of the thymus and account for the thymic epithelial tumors…”
Get full text
Journal Article -
18
Low total pathologic complete response rate to preoperative chemotherapy in patients with invasive lobular carcinomaof the breast
Published in Contemporary oncology (Poznan, Poland) (2019)“…Total pathologic complete response (tpCR; ypT0/is ypN0) after preoperative chemotherapy (PCT) is associated with better outcome in locally advanced breast…”
Get full text
Journal Article -
19
Study on compliance with breakthrough cancer pain guidelines by medical oncologists in Spain
Published in Journal of clinical oncology (20-05-2017)“…Abstract only e18260 Background: Breakthrough cancer pain (BTcP) has been shown to be a prevalent and poor prognostic factor for cancer patients, which remains…”
Get full text
Journal Article -
20
Anti-EGFR Antibody Plus Chemotherapy Treatment in a Patient with Synchronous Merkel Cell Carcinoma and Colorectal Cancer
Published in Curēus (Palo Alto, CA) (26-01-2021)“…Merkel cell carcinoma (MCC) is a rare neuroendocrine cutaneous malignancy. During early stages, surgery is the primary treatment followed by radiotherapy in…”
Get full text
Journal Article